471 related articles for article (PubMed ID: 12692225)
1. Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers.
Elkington R; Walker S; Crough T; Menzies M; Tellam J; Bharadwaj M; Khanna R
J Virol; 2003 May; 77(9):5226-40. PubMed ID: 12692225
[TBL] [Abstract][Full Text] [Related]
2. Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4
Frascaroli G; Lecher C; Varani S; Setz C; van der Merwe J; Brune W; Mertens T
Front Immunol; 2018; 9():1129. PubMed ID: 29887865
[TBL] [Abstract][Full Text] [Related]
3. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection.
Gibson L; Piccinini G; Lilleri D; Revello MG; Wang Z; Markel S; Diamond DJ; Luzuriaga K
J Immunol; 2004 Feb; 172(4):2256-64. PubMed ID: 14764694
[TBL] [Abstract][Full Text] [Related]
4. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.
Wills MR; Carmichael AJ; Mynard K; Jin X; Weekes MP; Plachter B; Sissons JG
J Virol; 1996 Nov; 70(11):7569-79. PubMed ID: 8892876
[TBL] [Abstract][Full Text] [Related]
5. HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition.
Jouand N; Bressollette-Bodin C; Gérard N; Giral M; Guérif P; Rodallec A; Oger R; Parrot T; Allard M; Cesbron-Gautier A; Gervois N; Charreau B
PLoS Pathog; 2018 Apr; 14(4):e1007041. PubMed ID: 29709038
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of cytomegalovirus-specific T-cell response in allogeneic hematopoietic stem cell recipients: the contribution of six frequently recognized, virus-encoded ORFs.
Nemeckova S; Krystofova J; Babiarova K; Hainz P; Musil J; Sroller V; Maly M; Stastna-Markova M
Transpl Infect Dis; 2016 Jun; 18(3):381-9. PubMed ID: 27061389
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.
Johnson DC; Hegde NR
Curr Top Microbiol Immunol; 2002; 269():101-15. PubMed ID: 12224504
[TBL] [Abstract][Full Text] [Related]
8. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response.
Steven NM; Annels NE; Kumar A; Leese AM; Kurilla MG; Rickinson AB
J Exp Med; 1997 May; 185(9):1605-17. PubMed ID: 9151898
[TBL] [Abstract][Full Text] [Related]
9. Identification of HLA-A*2402-restricted HCMV immediate early-1 (IE-1) epitopes as targets for CD8+ HCMV-specific cytotoxic T lymphocytes.
Lim JB; Kim HO; Jeong SH; Ha JE; Jang S; Lee SG; Lee K; Stroncek D
J Transl Med; 2009 Aug; 7():72. PubMed ID: 19698161
[TBL] [Abstract][Full Text] [Related]
10. Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients.
Calarota SA; Chiesa A; Scaramuzzi L; Adzasehoun KM; Comolli G; Mangione F; Esposito P; Baldanti F
J Clin Virol; 2014 Sep; 61(1):65-73. PubMed ID: 24961915
[TBL] [Abstract][Full Text] [Related]
11. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
[TBL] [Abstract][Full Text] [Related]
12. Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells.
Boppana SB; Britt WJ
Virology; 1996 Aug; 222(1):293-6. PubMed ID: 8806513
[TBL] [Abstract][Full Text] [Related]
13. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers.
Tan LC; Gudgeon N; Annels NE; Hansasuta P; O'Callaghan CA; Rowland-Jones S; McMichael AJ; Rickinson AB; Callan MF
J Immunol; 1999 Feb; 162(3):1827-35. PubMed ID: 9973448
[TBL] [Abstract][Full Text] [Related]
14. Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited.
Kern F; Surel IP; Faulhaber N; Frömmel C; Schneider-Mergener J; Schönemann C; Reinke P; Volk HD
J Virol; 1999 Oct; 73(10):8179-84. PubMed ID: 10482568
[TBL] [Abstract][Full Text] [Related]
15. Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection.
Wynn KK; Fulton Z; Cooper L; Silins SL; Gras S; Archbold JK; Tynan FE; Miles JJ; McCluskey J; Burrows SR; Rossjohn J; Khanna R
Blood; 2008 Apr; 111(8):4283-92. PubMed ID: 18270323
[TBL] [Abstract][Full Text] [Related]
16. Diverse specificities, phenotypes, and antiviral activities of cytomegalovirus-specific CD8+ T cells.
Jackson SE; Mason GM; Okecha G; Sissons JG; Wills MR
J Virol; 2014 Sep; 88(18):10894-908. PubMed ID: 25008941
[TBL] [Abstract][Full Text] [Related]
17. Identification of a conserved HLA-A2-restricted decapeptide from the IE1 protein (pUL123) of human cytomegalovirus.
Frankenberg N; Pepperl-Klindworth S; Meyer RG; Plachter B
Virology; 2002 Apr; 295(2):208-16. PubMed ID: 12033779
[TBL] [Abstract][Full Text] [Related]
18. Suppression of CD8+ T-cell recognition in the immediate-early phase of human cytomegalovirus infection.
Hesse J; Ameres S; Besold K; Krauter S; Moosmann A; Plachter B
J Gen Virol; 2013 Feb; 94(Pt 2):376-386. PubMed ID: 23100361
[TBL] [Abstract][Full Text] [Related]
19. Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation.
Sacre K; Nguyen S; Deback C; Carcelain G; Vernant JP; Leblond V; Autran B; Dhedin N
J Virol; 2008 Oct; 82(20):10143-52. PubMed ID: 18684826
[TBL] [Abstract][Full Text] [Related]
20. CD8 T cell-evasive functions of human cytomegalovirus display pervasive MHC allele specificity, complementarity, and cooperativity.
Ameres S; Besold K; Plachter B; Moosmann A
J Immunol; 2014 Jun; 192(12):5894-905. PubMed ID: 24808364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
